Branded and Biosimilar Ophthalmology

View buyer

Estimated value

goods

Awarded value

Suppliers

8

3 SME

Lots

4

4 awarded

Published

24 Nov 2025

Total lots

4

Awarded

4

0 pending

Estimated total

£146.6m

Awarded total

Lot 1cancelled

Aflibercept (Eylea®)

Award value

Start

End

Estimated

£89.8m

CPV

33600000
Awarded to 1 supplier
Lot 2cancelled

Aflibercept Biosimilar

Award value

Start

End

Estimated

£1

CPV

33600000
Lot 3cancelled

Ranibizumab vials and Pre-filled Syringes

Award value

Start

End

Estimated

£5.1m

CPV

33600000
Awarded to 2 suppliers
Lot 4cancelled

Faricimab (Vabysmo®)

Estimated
£51.7m

Start

End

Estimated

£51.7m

CPV

33600000
No suppliers awarded yet for this lot.